1. IL-2 signals through Sgk1 and inhibits proliferation and apoptosis in kidney cancer cells.
- Author
-
Amato R, Menniti M, Agosti V, Boito R, Costa N, Bond HM, Barbieri V, Tagliaferri P, Venuta S, and Perrotti N
- Subjects
- Cell Line, Tumor, Cell Survival, Gene Expression Regulation, Humans, Immediate-Early Proteins genetics, Immediate-Early Proteins metabolism, Kidney Neoplasms metabolism, Protein Serine-Threonine Kinases genetics, Protein Serine-Threonine Kinases metabolism, Receptors, Interleukin-2 analysis, Signal Transduction, Apoptosis, Cell Proliferation, Immediate-Early Proteins physiology, Interleukin-2 physiology, Kidney Neoplasms pathology, Protein Serine-Threonine Kinases physiology
- Abstract
The interleukin-2 is a cytokine that is essential for lymphocytic survival and function. Ectopic expression of the IL-2 receptor in epithelial tissues has been reported previously, although the functional significance of this expression is still being investigated. We provided novel structural and functional information on the expression of the IL-2 receptor in kidney cancer cells and in other normal and neoplastic human epithelial tissues. In A-498 kidney cancer cells, we showed that IL-2 binding to its own receptor triggers a signal transduction pathway leading to the inhibition of proliferation and apoptosis. We found that the inhibition of proliferation is associated with Erk1/2 dephosphorylation, whereas the survival signals appear to be mediated by Sgk1 activation. This investigation focuses on the IL-2 induced regulation of Sgk1 and describes a role of the IL-2 receptor and Sgk1 in the regulation of epithelial tumor cell death and survival.
- Published
- 2007
- Full Text
- View/download PDF